Small breakthroughs offer big hope of AIDS 'cure'

July 26, 2012 by Kerry Sheridan and Jean-Louis Santini

Small but significant breakthrough studies on people who have been able to overcome or control HIV were presented Thursday at a major world conference on ways to stem the three-decade-old disease.

One study focused on a group of 12 patients in France who began treatment on antiretroviral drugs within 10 weeks of becoming infected with human immunodeficiency virus, but then stopped the therapy after nearly three years.

The virus has stayed away for a median of six years in the group, known as the Visconti Cohort, which stands for "Virological and Immunological Studies in CONtrollers after Treatment Interruption."

This unique group of people did not completely eliminate HIV, but continued to possess it at an extremely low level in their cells and did not become sick.

"These results suggest that the antiretroviral treatment should be started very early after infection," said Charline Bacchus, lead researcher of the study at France's national AIDS research agency ANRS.

"Six years after interruption of treatment, patients treated early on in the post-infection period present a perfect ability to control the HIV infection."

Scientists are continuing to study the immune characteristics of this group for clues as to why they do not need prolonged medication. For most HIV patients, antiretroviral drugs must be taken for life.

There are currently 34 million people living with HIV worldwide. In low- and middle-income nations, which are the most affected by the pandemic, about eight million people are now taking antiretrovirals for treatment, about half those in need.

The second study involved two HIV-positive men whose DNA showed no trace of the virus eight and 17 months respectively after receiving stem cell transplants from an outside donor as treatment for blood cancer.

The men have been followed for two and three and a half years respectively, with no sign of the virus's return. Researchers have also noted they experienced a sharp decline in HIV antibodies, suggesting the virus is gone.

Their cases are different from the well-known "Berlin patient," American Timothy Brown, who is considered cured of HIV and leukemia five years after receiving similar bone marrow transplants from a rare donor naturally resistant to HIV, or lacking a CCR5 receptor.

The two men in the study received transplants from donors with the CCR5 receptor, which acts as a gateway allowing HIV to penetrate the cells, so they were not afforded protection against the virus by that mutation.

Researchers believe that by continuing to treat the men with antiretroviral drugs during the process, the medicine prevented the donor cells from becoming infected until they were able to provide the men with new immune defenses.

The study was presented at the 19th International AIDS Conference by Daniel Kuritzkes, professor of medicine at Brigham and Women's Hospital in Massachusetts.

Reacting to the news, Brown expressed "joy" at the potential for two more men to be free of HIV.

"As I have said many times before, I want everyone to be cured of this disease. We can only hope that this case and today's development represents the beginning of the end of this plague," he said in a statement.

A third study on how a cancer drug helped purge HIV from the cells of patients was described by lead researcher David Margolis of the University of North Carolina.

Researchers used the chemotherapy drug vorinostat to revive and so unmask latent HIV in the CD4+ T cells of eight trial patients who were also taking antiretroviral drugs to stop the virus from multiplying.

Margolis, whose study was published Wednesday in the British journal Nature, told reporters that researchers are energized toward the goal of finding a cure for HIV, even if it remains many years away.

"You cannot argue with the value of the goal and we cannot get there without working on it and I cannot say how long it will take," he said.

"But I think there is a clear path and we can make progress."

Explore further: Drug helps purge hidden HIV virus, study shows

Related Stories

Drug helps purge hidden HIV virus, study shows

March 8, 2012
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.

Bone marrow transplant eliminates signs of HIV infection

July 26, 2012
Two men with longstanding HIV infections no longer have detectable HIV in their blood cells following bone marrow transplants. The virus was easily detected in blood lymphocytes of both men prior to their transplants but ...

AIDS cure may have two main pathways: experts (Update)

July 24, 2012
Investigators are looking into two main paths toward a cure for AIDS, based on the stunning stories of a small group of people around the world who have been able to overcome the disease.

Gene therapy reduces HIV levels in small trials

September 20, 2011
(Medical Xpress) -- This weekend at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois, researchers from two different study groups, one on the east coast and one on the west coast, ...

Pioneering research shows drug can purge dormant HIV

July 25, 2012
Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.